Market revenue in 2023 | USD 7,120.5 million |
Market revenue in 2030 | USD 8,681.9 million |
Growth rate | 2.9% (CAGR from 2023 to 2030) |
Largest segment | Clinical chemistry |
Fastest growing segment | Human & Tumor Genetics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Human & Tumor Genetics, Clinical Chemistry, Medical Microbiology & Cytology, Other Esoteric Tests |
Key market players worldwide | Labcorp Holdings Inc, Qiagen NV, Eurofins Scientific SE, Quest Diagnostics Inc, OPKO Health Inc, Siemens Healthineers AG ADR, NeoGenomics Inc, Fresenius Medical Care AG, Sonic Healthcare Ltd, Charles River Laboratories International Inc, SYNLAB Group, Mayo Clinic |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical laboratory service market will help companies and investors design strategic landscapes.
Clinical chemistry was the largest segment with a revenue share of 47.71% in 2023. Horizon Databook has segmented the Italy clinical laboratory service market based on human & tumor genetics, clinical chemistry, medical microbiology & cytology, other esoteric tests covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing demand for rapid diagnostic procedures and the rising prevalence of infectious diseases in the country are driving the clinical laboratory services market in Italy. The presence of favorable government initiatives and the development of independent diagnostic centers are expected to further boost market growth during the forecast period.
Italy was one of the worst-hit countries during the COVID-19 pandemic. However, its diagnostic capacity increased very slowly compared to other nations such as the UK and Germany. It has the capacity to conduct only 150,000 tests per week, which is among the lowest in the region.
Thus, the entry of newer players with higher efficiency and increasing the diagnostic capacity of existing laboratories are expected to create competition among market players and support market growth in the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy clinical laboratory service market , including forecasts for subscribers. This country databook contains high-level insights into Italy clinical laboratory service market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account